Medication Shortages Erode Trust and Workforce in European Pharmacies

The ongoing crisis of medication shortages across Europe is straining pharmacy teams to their limits, leading to frustration among healthcare professionals and patients alike. A recent survey conducted across 28 European countries reveals that 61% of respondents reported no improvement in the medication supply situation compared to the previous year. The Pharmaceutical Group of the European Union (PGEU) has described this trend as alarming.

Pharmacy teams now spend an average of nearly 11 hours per week managing medication shortages, a figure that has tripled over the past decade. This increased burden not only detracts from resources allocated to other essential health services but also undermines patient trust, according to the report.

Clare Fitzell, president of PGEU, highlighted the unacceptable nature of the current state of affairs, noting that each instance of medication scarcity affects concerned patients and diligent pharmacists who are striving for alternative solutions.

The most frequently reported shortages continue to involve cardiovascular medications, anti-infectives, and drugs for neurological conditions. Furthermore, 64% of surveyed countries indicated shortages of medical products across various categories. Although pharmacies perceive a slight reduction in the total number of shortages, the time required to resolve these issues has significantly increased due to the dwindling number of available alternatives.

While Fitzell acknowledged that some countries have made it easier for pharmacies to implement substitutions, compounding, or dosage adjustments--thus utilizing pharmacists' expertise more effectively--she suggested that the pace of implementing further competency expansions could be improved. She emphasized the potential of pharmacists to contribute significantly if provided with the necessary tools, opportunities, and resources.

The report indicates that patients in all surveyed countries are equally frustrated by the persistent shortages. The most severe consequences identified by the respondents include interruptions in treatment (82%), increased out-of-pocket expenses due to more expensive or non-reimbursable alternatives (61%), and diminished trust in medications, pharmacies, and the overall healthcare system (61%).

Additionally, pharmacy staff are increasingly affected by the challenging supply situation. The heightened demands in terms of time and energy, coupled with rising administrative burdens, have led to decreased job satisfaction among employees, as the report points out.